About Maiken Keson-Brookes
Maiken Keson-Brookes is an executive officer at Solstice Oncology.
Experience
This experience comes from Maiken Keson-Brookes's profile and from SEC filings. For roles taken from filings, the years are when the filings name Maiken Keson-Brookes in the role, so the role may have started earlier or lasted longer.
Solstice Oncology, Inc. Current
Chief Operating Officer and General Counsel
2026 – Present · Boston, MA
Develops cancer immunotherapy for patients before surgery, beginning with colon cancer.
BI
Biotech
Consultant
2025 – 2026
MO
Mural Oncology
Chief Legal Officer
2023 – 2025
RT
Rubius Therapeutics
Chief Legal Officer and Corporate Secretary
2019 – 2022
SI
Synlogic, Inc.
General Counsel
2017 – 2019
UN
uniQure
SVP and General Counsel
2016 – 2017
FP
FORUM Pharmaceuticals (formerly Envivo Pharmaceuticals)
SVP and General Counsel
2011 – 2016
EP
EnVivo Pharmaceuticals
Head of Legal
2010 – 2011
GE
Genzyme
Legal Consultant
2010 – 2011
BI
Biogen Idec
Director, Legal (2008 – 2009)
Associate Director, International Legal (2004 – 2008)
2004 – 2009
AG
Affinion Group
General Counsel
2000 – 2004
RL
Royal Danish Embassy in London
Legal & Consular Officer
1997 – 2000
Key Colleagues at Startups
The people Maiken Keson-Brookes works with at each company, as listed on that company's latest Form D.
Solstice Oncology, Inc. · Form D, Mar 9, 2026
David Feltquate
Executive officer
AL
Andrew Levin
Director
Julie Grant
Director
Emily Minkow
Director
Morgan Haller
Director
CL
Caroline Loew
President & CEO, Solstice Oncology, director